DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MAXALT

« Back to Dashboard

Clinical Trials for Maxalt

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00360282	Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?	Completed	Merck Sharp & Dohme Corp.	N/A	The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00360282	Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?	Completed	University of Pittsburgh	N/A	The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
NCT00397254	Two Rizatriptan Prescribing Portions for Treatment of Migraine	Completed	Merck Sharp & Dohme Corp.	Phase 4	The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month.
NCT00397254	Two Rizatriptan Prescribing Portions for Treatment of Migraine	Completed	Clinvest	Phase 4	The primary objective of this study is to evaluate a clinical limit (CL) of rizatriptan (9 rizatriptan 10mg Orally Disintegrating Tablet (ODT) per month) versus (vs.) a formulary limit (FL) of rizatriptan (27 rizatriptan 10mg ODT per month) as measured by the number of days of migraine per month.

Clinical Trial Conditions for Maxalt

Condition Name

Condition Name for Maxalt
Intervention	Trials
Migraine	2
Chronic Post-traumatic Headache	1
Vestibular Migraine	1
Migrainous Vertigo	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Maxalt
Intervention	Trials
Migraine Disorders	5
Headache	2
Motion Sickness	1
Vertigo	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Maxalt

Trials by Country

Trials by Country for Maxalt
Location	Trials
United States	13

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Maxalt
Location	Trials
California	2
Pennsylvania	2
Minnesota	1
Washington	1
Illinois	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Maxalt

Clinical Trial Phase

Clinical Trial Phase for Maxalt
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	2
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Maxalt
Clinical Trial Phase	Trials
Completed	4
Withdrawn	1
Recruiting	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Maxalt

Sponsor Name

Sponsor Name for Maxalt
Sponsor	Trials
Merck Sharp & Dohme Corp.	5
Clinvest	1
University of Pittsburgh	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Maxalt
Sponsor	Trials
Other	5
Industry	5

Export unavailable in trial.
Subscribe for complete access.